E. Aravantinou-Fatorou | Prof. Nikolaos Korfiatishttps://nkorf.github.io/authors/e.-aravantinou-fatorou/E. Aravantinou-FatorouHugoBlox Kit (https://hugoblox.com)en-usThu, 01 Jan 2026 00:00:00 +0000Clinico-pathological and genomic features of HER2-low early Breast Cancer (eBC). Results of retrospective analysis of seven adjuvant trials by the Hellenic Cooperative Oncology Group (HeCOG)https://nkorf.github.io/publications/lakis2026ccr/Thu, 01 Jan 2026 00:00:00 +0000https://nkorf.github.io/publications/lakis2026ccr/Profiling of 1491 tumors from four HeCOG early breast cancer (eBC) studies using targeted DNA sequencing and central pathology reviewhttps://nkorf.github.io/publications/papadopoulou2026esmoopen/Thu, 01 Jan 2026 00:00:00 +0000https://nkorf.github.io/publications/papadopoulou2026esmoopen/Clinico-pathological and genomic features of HER2-low early Breast Cancer (eBC). Results of retrospective analysis of seven adjuvant trials by the Hellenic Cooperative Oncology Group (HeCOG)https://nkorf.github.io/publications/lakis2025sabcs/Wed, 01 Jan 2025 00:00:00 +0000https://nkorf.github.io/publications/lakis2025sabcs/